Abstract
Klebsiella pneumoniae is one of the most important hospital pathogens, particularly concerning the multidrug-resistant strain ESBL+. The aim of this study was to evaluate nosocomial infections with K. pneumoniae ESBL+ in the context of infection location, risk factors, and prognosis. This hospital study was conducted retrospectively and covered a 3 months’ period. The infection with K. pneumoniae ESBL+ was diagnosed in 36 patients (19 women and 17 men) of the mean age of 74.2 ± 14.8 years. The number of infected patients amounted to 2.2% of all patients admitted to Czerniakowski Hospital in Warsaw, Poland, over the study time. Twenty of these patients died (13 women and 7 men), representing 14% of all hospital deaths at the time. The infection with K. pneumoniae ESBL+ occurred most frequently in the department of internal diseases, and rarely in neurology or intensive care wards. Bacteria was most often isolated from the urine, with the most distinct association between the use of urinary catheters and death (p = 0.019). We conclude that infections with K. pneumoniae ESBL+ were associated with over 55% mortality and usually occurred in the setting of internal diseases. Deaths due to K. pneumoniae ESBL+ infection were significantly related to the use of urinary bladder catheters.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ben-Ami R, Schwaber MJ, Navon-Venezia S, Schwartz D, Giladi M, Chmelnitsky I, Leavitt A, Carmeli Y (2006) Influx of extended-spectrum β-lactamase-producing Enterobacteriaceae into the hospital. Clin Infect Dis 42:925–934
Birgand G, Armand-Lefevre L, Lolom I, Ruppe E, Andremont A, Lucet JC (2013) Duration of colonization by extended-spectrum β-lactamase-producing Enterobacteriaceae after hospital discharge. Am J Infect Control 41:443–447
Bradford PA (2001) Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 14:933–951
Demirdag K, Hosoglu S (2010) Epidemiology and risk factors for ESBL-producing Klebsiella pneumoniae: a case control study. J Infect Dev Ctries 4:717–722
Du B, Long Y, Liu H, Chen D, Liu D, Xu Y, Xie X (2002) Extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumonia bloodstream infection: risk factors and clinical outcome. Intensive Care Med 28:1718–1723
ECDC (2012) Antimicrobial resistance surveillance in Europe 2012. http://ecdc.europa.eu/en/publications/Publications/antimicrobial-resistance-surveillance-europe-2012.pdf. Accessed 15 Oct 2016
Empel J, Baraniak A, Literacka E, Mrowka A, Fiett J, Sadowy E, Hryniewicz W, Gniadkowski M, Beta-PL Study Group (2008) Molecular survey of beta-lactamases conferring resistance to newer beta-lactams in Enterobacteriaceae isolates from Polish hospitals. Antimicrob Agents Chemother 52:2449–2454
Kang CI, Kim SH, Kim DM, Park WB, Lee KD, Kim HB, Oh MD, Kim EC, Choe KW (2004) Risk factors for ciprofloxacin resistance in bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Microb Drug Resist 10:71–76
Kim BN, Woo JH, Kim MN, Ryu J, Kim YS (2002) Clinical implications of extended-spectrum β-lacatamase-producing Klebsiella pneumoniae bacteraemia. J Hosp Infect 52:99–106
Knothe H, Shah P, Kremery V, Antal M, Mitsuhashi S (1983) Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumonia and Serratia marcescens. Infection 11:315–317
Lautenbach E, Patel JB, Bilker WB, Edelstein PH, Fishman NO (2001) Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis 32:1162–1171
Lee JC, Lee NY, Lee HC, Huang WH, Tsui KC, Chang CM, Lee CC, Chen PL, Wu CJ, Hsueh PR, Ko WC (2012) Clinical characteristics of urosepsis caused by extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella pneumonia and their emergence in the community. J Microbiol Immunol Infect 45:127–133
Lin HC, Lai LA, Wu JY, Su YM, Chang SP, Hsueh YM (2013) Risk factors for acquiring extended-spectrum β-lactamase-producing Enterobacteriaceae in geriatric patients with multiple comorbidities in respiratory care wards. Geriatr Gerontol Int 13:663–671
Ludden C, Cormican M, Vellinga A, Johnson JR, Austin B, Morris D (2015) Colonisation with ESBL-producing and carbapenemase-producing Enterobacteriaceae, vancomycin-resistant enterococci, and meticillin-resistant Staphylococcus aureus in a long-term care facility over one year. BMC Infect Dis 15:168
Mendelson G, Hait V, Ben-Israel J, Gronich D, Granot E, Raz R (2005) Prevalence and risk factors of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in an Israeli long-term care facility. Eur J Clin Microbiol Infect Dis 24:17–22
Nordmann P (2014) Carbapenemase-producing Enterobacteriaceae: overview of a major public health challenge. Med Mal Infect 44:51–56
Paluchowska P, Skałkowska M, Spelak A, Budak A (2012) Occurrence of alert pathogens in hospital environment. Part I. ESBL-producing Enterobacteriaceae strains. Med Dosw Mikrobiol 64(1):35–43. (Article in Polish)
Paterson DL, Ko WC, Von Gottberg A, Casellas JM, Mulazimoglu L, Klugman KP, Bonomo RA, Rice LB, McCormack JG, Yu VL (2001) Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory. J Clin Microbiol 39:2206–2212
Paterson DL, Ko WC, Von Gottberg A, Mohapatra S, Casellas JM, Goossens H, Mulazimoglu L, Trenholme G, Klugman KP, Bonomo RA, Rice LB, Wagener MM, McCormack JG, Yu VL (2004) Antibiotic therapy for Klebsiella pneumonia bacteremia: implications of production of extended-spectrum β-lactamases. Clin Infect Dis 39:31–37
Pitout JD, Laupland KB (2008) Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 8:159–166
Podschun R, Ullmann U (1998) Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev 11:589–603
Prestes-Carneir LE, Azevedo AM, Nakashima MA, Xavier JM, Cabral C (2015) Frequency and antimicrobial susceptibility of pathogens at tertiary public hospital, Sao Paulo, Brazil. Southeast Asian J Trop Med Public Health 46:276–284
Salsano A, Giacobbe DR, Sportelli E, Olivieri GM, Brega C, Di Biase C, Coppo E, Marchese A, Del Bono V, Viscoli C, Santini F (2016) Risk factors for infections due to carbapenem-resistant Klebsiella pneumoniae after open heart surgery. Interact Cardiovasc Thorac Surg 23:762–768
Schwaber M, Navon-Venezia S, Kaye KS, Ben-Ami R, Schwartz D, Carmeli Y (2006) Clinical and economic impact of bacteremia with extended-spectrum-beta-lactamase-producing Enterobacteriaceae. Antimicrob Agents Chemother 50:1257–1262
Sekowska A, Kamińska D, Nakonowska B, Gospodarek E (2012) Nosocomial outbreak due to Klebsiella pneumoniae at a neurosurgery unit. Pol J Microbiol 61:311–313
Sekowska A, Gospodarek E, Kusza K (2014) The prevalence of infections and colonisation with Klebsiella pneumoniae strains isolated in ICU patients. Anaesthesiol Intensive Ther 46:295–298
Shanthi M, Sekar U (2010) Extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumonia: risk factors for infection and impact of resistance on outcomes. J Assoc Physicians India 58(Suppl):41–44
Steinmann J, Kaase M, Gatermann S, Popp W, Steinmann E, Damman M, Paul A, Saner F, Buer J, Rath P (2011) Outbreak due to a Klebsiella pneumoniae strain harbouring KPC-2 and VIM-1 in a German university hospital, July 2010 to January 2011. Euro Surveill 16(33):19944
Superti SV, Augusti G, Zavascki AP (2009) Risk factors for and mortality of extended-spectrum-β-lactamase-producing Klebsiella pneumoniae and Escherichia coli nosocomial bloodstream infections. Rev Inst Med Trop Sao Paulo 51:211–216
Tumbarello M, Spanu T, Sanguinetti M, Citton R, Montuori E, Leone F, Fadda G, Cauda R (2006) Bloodstream infections caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: risk factors, molecular epidemiology, and clinical outcome. Antimicrob Agents Chemother 50:498–504
Tumbarello M, Sanguinetti M, Montuori E, Trecarichi EM, Posteraro B, Fiori B, Citton R, D’Inzeo T, Fadda G, Cauda R, Spanu T (2007) Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-β-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment. Antimicrob Agents Chemother 51:1987–1994
Tuon FF, Bianchet LC, Penteado-Filho SR (2010) Epidemiology of extended spectrum beta-lactamase producing Enterobacter bacteremia in a Brazilian hospital. Rev Soc Bras Med Trop 43:452–454
Tuon FF, Kruger M, Terreri M, Penteado-Filho SR, Gortz L (2011) Klebsiella ESBL bacteremia-mortality and risk factors. Braz J Infect Dis 15:594–598
Wielders CC, van Hoek AH, Hengeveld PD, Veenman C, Dierikx CM, Zomer TP, Smit LA, van der Hoek W, Heederik DJ, de Greeff SC, Maassen CB, van Duijkeren E (2017) Extended-spectrum β-lactamase- and pAmpC-producing Enterobacteriaceae among the general population in a livestock-dense area. Clin Microbiol Infect 23(2):120.e1–120.e8
Yang CC, Wu CH, Lee CT, Liu HT, Chen JB, Chiu CH, Chen CH, Chuang FR (2014) Nosocomial extended-spectrum beta-lactamase-producing Klebsiella pneumoniae bacteremia in hemodialysis patients and the implications for antibiotic therapy. Int J Infect Dis 28:3–7
Conflicts of Interest
The authors declared no competing interests in relation to this article.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Starzyk-Łuszcz, K., Zielonka, T.M., Jakubik, J., Życińska, K. (2017). Mortality Due to Nosocomial Infection with Klebsiella pneumoniae ESBL+ . In: Pokorski, M. (eds) Clinical Management of Pulmonary Disorders and Diseases. Advances in Experimental Medicine and Biology(), vol 1022. Springer, Cham. https://doi.org/10.1007/5584_2017_38
Download citation
DOI: https://doi.org/10.1007/5584_2017_38
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-69544-0
Online ISBN: 978-3-319-69545-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)